BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 33493696)

  • 1. The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude.
    Webb GJ; Ryan RP; Marshall TP; Hirschfield GM
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2587-2596. PubMed ID: 33493696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
    Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis.
    Lamba M; Ngu JH; Stedman CAM
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):573-579.e1. PubMed ID: 32526342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center.
    Nejad SEM; Heiat M; Javanbakht M; Alavian SM; Haris MAA
    BMC Gastroenterol; 2024 Jan; 24(1):17. PubMed ID: 38178070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nationwide study of autoimmune liver diseases in the Faroe Islands: Incidence, prevalence, and causes of death 2004 - 2021.
    Nielsen KR; Midjord J; Johannesen HL; Grønbæk H
    Int J Circumpolar Health; 2023 Dec; 82(1):2221368. PubMed ID: 37300838
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.
    Boberg KM; Aadland E; Jahnsen J; Raknerud N; Stiris M; Bell H
    Scand J Gastroenterol; 1998 Jan; 33(1):99-103. PubMed ID: 9489916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study.
    Gao W; Peng C; Wang Z; Li Y; Liu M
    J Transl Med; 2024 May; 22(1):425. PubMed ID: 38704596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
    Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
    JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database.
    Lim J; Kim HJ
    Orphanet J Rare Dis; 2024 Apr; 19(1):178. PubMed ID: 38685058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differences in post-liver transplant outcomes of patients with autoimmune hepatitis who present with overlapping autoimmune liver diseases.
    Lee DU; Ponder R; Lee K; Menegas S; Fan GH; Chou H; Jung D; Lee K; Hastie DJ; Urrunaga NH
    Hepatol Int; 2023 Jun; 17(3):720-734. PubMed ID: 36575337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in liver transplantation for autoimmune liver diseases: a Canadian study.
    Murillo Perez CF; Ivanics T; Claasen MPAW; Yoon P; Wallace D; Selzner N; Hirschfield GM; Hansen BE; Sapisochin G
    Can J Surg; 2022; 65(5):E665-E674. PubMed ID: 36223935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital.
    Taneja S; Mehtani R; De A; Mitra S; Rathi S; Verma N; Premkumar M; Minz R; Duseja A; Das A; Singh V; Dhiman RK; Chawla YK
    J Clin Exp Hepatol; 2023; 13(2):241-251. PubMed ID: 36950480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta-analysis.
    Jensen AH; Winther-Sørensen M; Burisch J; Bergquist A; Ytting H; Gluud LL; Wewer Albrechtsen NJ
    Liver Int; 2023 Nov; 43(11):2479-2491. PubMed ID: 37752719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in clinical practice: epidemiology of autoimmune liver diseases.
    Trivedi PJ; Hirschfield GM
    Gut; 2021 Oct; 70(10):1989-2003. PubMed ID: 34266966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Rocha HC; Vilela EG
    Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history.
    Deneau M; Jensen MK; Holmen J; Williams MS; Book LS; Guthery SL
    Hepatology; 2013 Oct; 58(4):1392-400. PubMed ID: 23686586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Posttransplant Mortality for Autoimmune Hepatitis Compared With Other Autoimmune Liver Diseases.
    Lee JY; Danford CJ; Patwardhan VR; Bonder A
    J Clin Gastroenterol; 2020 Aug; 54(7):648-654. PubMed ID: 31651572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of the possible impact of hepatitis viruses on the development and course of autoimmune liver diseases].
    Sbikina ES; Vinnitskaya EV; Batskikh SN; Sandler YG; Saliev KG; Khaimenova TY; Bordin DS
    Ter Arkh; 2023 Mar; 95(2):173-178. PubMed ID: 37167134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis.
    Dyson JK; Blain A; Foster Shirley MD; Hudson M; Rushton S; Jeffreys Jones DE
    JHEP Rep; 2021 Feb; 3(1):100202. PubMed ID: 33474546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.